fda warning letter hims compounded semaglutide 2025 π¨ Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Hims & Hers May Discontinue
Description
For the science, see What Is Retatrutide
FAQ Q1: Is there a specific age cutoff for taking GLP-1 medications like Ozempic or Wegovy

Slow, steady progress is easier to keep long term, which is one reason semaglutide is not considered a quick fix, but a long-term tool

Whilst GLP-1 receptor agonists are not diuretics and do not typically cause polyuria, several factors associated with treatmentincluding improved glycaemic control, weight loss, and gastrointestinal effectscan influence urinary patterns

Plans start at $199 a month
